RAPS recognizes that the current situation in Ukraine impacts our members and customers on many levels. If you are directly impacted by the current situation in the region and are challenged to meet your deadlines or obligations to RAPS, please reach out to raps@raps.org so that we can defer those challenges. Your health and safety are paramount to us.

Regulatory Focus™ > News Articles > Advertising and Promotion of In Vitro Diagnostic Products

Advertising and Promotion of In Vitro Diagnostic Products

Posted 01 May 2011 | By Seth Mailhot, JD

The laws and regulations governing the advertising and promotion of in vitro diagnostic (IVD) devices are complex. Various regulatory agencies and entities share overlapping authority over IVDs, and, therefore, a substantial amount of regulatory understanding is required to effectively navigate the systems. The risks of noncompliance with regulatory requirements are significant, as shown by the $262 million civil False Claims Act settlement paid by Quest Diagnostics in 2009.

 

© 2022 Regulatory Affairs Professionals Society.

Regulatory Focus newsletters

All the biggest regulatory news and happenings.

Subscribe